We saw a strong performance by major biotech players, but a challenging environment for the rest of the industry. Read more in our 2013 industry report
Beyond Borders: global biotech report 2013
mHealth: Mobile tech poised to enable new era in health care
Pharma's $100 billion growth gap
Cash on the prescription 2012
Beyond borders: global biotech report 2012
Progressions 2012: health care everywhere
What Europe has to offer biotechnology companies
Medical technology report 2011
Beyond Borders 2011: global biotechnology report
Finding sustainability in biotechnology, pharmaceutical and medical technology
Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.
Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.
We cover key issues in these areas:
Commercial industry Leader
Contact | +352 42 124 8308
Connect with us
Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.
As big pharma faces a widening growth gap, our Firepower Index highlights industry's capacity for deals in 2013 and beyond.
Here are insights into the role of today's CIO, including an interview with Roche CIO, Werner Boeing.
Conversations in health care, a special edition, features interviews with health care leaders from around the world.